At the ASCO Annual Meeting held on May 29, 2026, Bristol-Myers Squibb announced positive outcomes in its research on multiple myeloma treatments.
Pfizer also shared encouraging data regarding its lung cancer therapies, contributing to the overall optimism surrounding cancer research at the event.
The ASCO meeting continues to serve as a vital platform for presenting groundbreaking advancements in cancer treatment and research.